Management of multidrug resistant Gram-negative bacilli infections in solid organ transplant recipients: SET/GESITRA-SEIMC/REIPI recommendations

J. M. Aguado, J. T. Silva, M. Fernández-Ruiz, E. Cordero, J. Fortún, C. Gudiol, L. Martínez-Martínez, E. Vidal, L. Almenar, B. Almirante, R. Cantón, J. Carratalá, J. J. Caston, E. Cercenado, C. Cervera, J. M. Cisneros, M. G. Crespo-Leiro, V. Cuervas-Mons, J. Elizalde-Fernández, M. C. FariñasJ. Gavaldà, M. J. Goyanes, B. Gutiérrez-Gutiérrez, D. Hernández, O. Len, R. López-Andujar, F. López-Medrano, P. Martín-Dávila, M. Montejo, A. Moreno, A. Oliver, A. Pascual, E. Pérez-Nadales, A. Román-Broto, R. San-Juan, D. Serón, A. Solé-Jover, M. Valerio, P. Muñoz, J. Torre-Cisneros

Research output: Contribution to journalReview articleResearchpeer-review

37 Citations (Scopus)

Abstract

© 2017 Elsevier Inc. Solid organ transplant (SOT) recipients are especially at risk of developing infections by multidrug resistant (MDR) Gram-negative bacilli (GNB), as they are frequently exposed to antibiotics and the healthcare setting, and are regulary subject to invasive procedures. Nevertheless, no recommendations concerning prevention and treatment are available. A panel of experts revised the available evidence; this document summarizes their recommendations: (1) it is important to characterize the isolate's phenotypic and genotypic resistance profile; (2) overall, donor colonization should not constitute a contraindication to transplantation, although active infected kidney and lung grafts should be avoided; (3) recipient colonization is associated with an increased risk of infection, but is not a contraindication to transplantation; (4) different surgical prophylaxis regimens are not recommended for patients colonized with carbapenem-resistant GNB; (5) timely detection of carriers, contact isolation precautions, hand hygiene compliance and antibiotic control policies are important preventive measures; (6) there is not sufficient data to recommend intestinal decolonization; (7) colonized lung transplant recipients could benefit from prophylactic inhaled antibiotics, specially for Pseudomonas aeruginosa; (8) colonized SOT recipients should receive an empirical treatment which includes active antibiotics, and directed therapy should be adjusted according to susceptibility study results and the severity of the infection.
Original languageEnglish
Pages (from-to)36-57
JournalTransplantation Reviews
Volume32
Issue number1
DOIs
Publication statusPublished - 1 Jan 2018

Fingerprint Dive into the research topics of 'Management of multidrug resistant Gram-negative bacilli infections in solid organ transplant recipients: SET/GESITRA-SEIMC/REIPI recommendations'. Together they form a unique fingerprint.

Cite this